These findings led us to postulate a tumor suppressor activity of miR-181a that we first tested by overexpressing or knocking-down miR-181a in the FLT3-ITD positive MV4-11 AML cell line by lentiviral infection (Figure 1A). Here, FLT3 is linked to neoplasm.